HS (hidradenitis suppurativa) affects thousands – often silently – but it can cause long-term pain, scarring and distress.
TipRanks on MSN
Incyte’s Phase 3 Study on Ruxolitinib Cream for Hidradenitis Suppurativa: A Market Game-Changer?
Incyte (($INCY)) announced an update on their ongoing clinical study. Incyte Corporation is currently conducting a Phase 3 clinical study titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback